Select Eye Care

Compiled by PlainTrial · August 8, 2026

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Select Eye Care sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Select Eye Care: 1 sponsored US clinical trial, 1 recruiting.

Select Eye Care sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Primary Open Angle Glaucoma (POAG), with 1 trials.

Select Eye Care is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING NA

Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma

NCT07147647

Therapeutic Areas

Primary Open Angle Glaucoma (POAG) 1

What is open in the Select Eye Care pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Primary Open Angle Glaucoma (POAG) (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Select Eye Care: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Select Eye Care sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Select Eye Care sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

1200 Pharma · 2 trials · 50% recruiting
1ST Biotherapeutics · 2 trials · 50% recruiting
3 Waves Wellness · 2 trials · 0% recruiting
3EO Health · 2 trials · 0% recruiting

Sponsors near 100% open enrollment (± trial volume)

AAVantgarde Bio Srl · 100% recruiting · 2 trials
Acorn Biolabs · 100% recruiting · 3 trials
Acrivon Therapeutics · 100% recruiting · 2 trials
ADARx Pharmaceuticals · 100% recruiting · 4 trials

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Select Eye Care page

1 registered trials is a research-attention snapshot, not an endorsement of Select Eye Care or any single study.

1 of Select Eye Care's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
Primary Open Angle Glaucoma (POAG) is the condition Select Eye Care studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Primary Open Angle Glaucoma (POAG) trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Select Eye Care pipeline card: 1 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.